Skip to content


Dr. Linda Liang brings over 20 years of biologics discovery and development experience. She joined Bonum Therapeutics in 2023. Prior to Bonum, she held senior positions in antibody discovery and early development at Pionyr Immunotherapeutics, Bristol-Myers Squibb, Merck, Schering-Plough, and Organon where she advanced programs in immuno-oncology, autoimmune and inflammatory diseases, and metabolic diseases. Linda received her Ph.D. in Immunology from the University of California, Berkeley.